Weimin Yang

948 total citations
65 papers, 723 citations indexed

About

Weimin Yang is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weimin Yang has authored 65 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Pharmacology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weimin Yang's work include Traditional Chinese Medicine Analysis (10 papers), Flavonoids in Medical Research (9 papers) and Phytochemistry and Bioactive Compounds (6 papers). Weimin Yang is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Flavonoids in Medical Research (9 papers) and Phytochemistry and Bioactive Compounds (6 papers). Weimin Yang collaborates with scholars based in China, United States and Macao. Weimin Yang's co-authors include Chuang Xiao, Ruo‐Pan Huang, Dong‐Hua Yang, Zhi Shi, Zhe‐Sheng Chen, Ruochun Huang, Jun-Jiang Chen, Chen Chen, Qi Zhou and Shibo Sun and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Weimin Yang

62 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weimin Yang China 15 299 144 101 92 86 65 723
Bin Huang China 18 352 1.2× 61 0.4× 101 1.0× 75 0.8× 120 1.4× 60 990
Haibo Cheng China 21 506 1.7× 123 0.9× 134 1.3× 89 1.0× 114 1.3× 79 1.1k
Xinhua Xia China 19 529 1.8× 87 0.6× 94 0.9× 89 1.0× 74 0.9× 62 1.1k
Ziming Zhao China 21 374 1.3× 78 0.5× 58 0.6× 39 0.4× 74 0.9× 56 1.1k
Huishu Guo China 22 478 1.6× 58 0.4× 140 1.4× 90 1.0× 106 1.2× 48 1.2k
Sijin Yang China 18 489 1.6× 57 0.4× 121 1.2× 121 1.3× 59 0.7× 75 981
Geng Zhang China 17 230 0.8× 62 0.4× 54 0.5× 106 1.2× 69 0.8× 57 742
Marialuisa Piccolo Italy 19 385 1.3× 65 0.5× 49 0.5× 98 1.1× 198 2.3× 42 973
Fereshteh Asgharzadeh Iran 16 232 0.8× 59 0.4× 64 0.6× 60 0.7× 114 1.3× 73 868

Countries citing papers authored by Weimin Yang

Since Specialization
Citations

This map shows the geographic impact of Weimin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Yang more than expected).

Fields of papers citing papers by Weimin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Yang. The network helps show where Weimin Yang may publish in the future.

Co-authorship network of co-authors of Weimin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Yang. A scholar is included among the top collaborators of Weimin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Yang. Weimin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Rui, et al.. (2025). Reduced Thioredoxin Regulates IL-1β Secretion via NLRP3 of IL-1β+ Alveolar Macrophages in COPD. Journal of Inflammation Research. Volume 18. 8563–8578. 2 indexed citations
2.
Wang, Mingqiang, Chaoyue Zhang, Qian Yi, et al.. (2025). Isoforskolin, adenylate cyclase agonist, inhibits endothelial-to-mesenchymal transition in atherosclerosis. Phytomedicine. 139. 156520–156520.
3.
Shi, Rui, Fang Wang, Chaozhong Li, et al.. (2025). Ferroptosis-related genes MDM2 and CDKN1A as potential biomarkers for COPD. Journal of Inflammation. 22(1). 49–49. 1 indexed citations
4.
Ma, Rui, Rong Guo, Meiling Shen, et al.. (2024). Structural optimization and bioactivity evaluation of 2-(Methylcarbonylamino) thiazole derivatives as novel PDE4B inhibitors. Tetrahedron. 167. 134250–134250. 2 indexed citations
5.
6.
7.
Fang, Yan, Chuang Xiao, Yaping Liang, et al.. (2023). Synergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models. Journal of Inflammation Research. Volume 16. 5989–6001. 6 indexed citations
8.
Huang, Rong, Ruiqin Zhang, Chuang Xiao, et al.. (2023). Gastrodin and Gastrodigenin Improve Energy Metabolism Disorders and Mitochondrial Dysfunction to Antagonize Vascular Dementia. Molecules. 28(6). 2598–2598. 26 indexed citations
9.
Liu, Weijun, Lihuan Zhang, Yutao Wang, et al.. (2023). hsa-mir-(4328, 4422, 548z and -628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target. Acta Diabetologica. 60(7). 929–942. 3 indexed citations
10.
Wu, Xiao Y., Runfeng Li, Zhengshi Lin, et al.. (2023). Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice. Frontiers in Microbiology. 14. 1137369–1137369. 11 indexed citations
11.
Xiao, Chuang, et al.. (2021). Research Advances in COPD Drugs and Novel Targets. Nano LIFE. 11(3). 2140008–2140008. 3 indexed citations
12.
Weng, Zhiying, Hongyan Wang, Rui Shi, et al.. (2021). Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ. Evidence-based Complementary and Alternative Medicine. 2021. 1–20. 3 indexed citations
13.
Lu, Jun, Xin Ma, Na Li, et al.. (2020). Donepezil down‐regulates propionylation, 2‐hydroxyisobutyrylation, butyrylation, succinylation, and crotonylation in the brain of bilateral common carotid artery occlusion‐induced vascular dementia rats. Clinical and Experimental Pharmacology and Physiology. 47(10). 1731–1739. 12 indexed citations
14.
Yang, Weimin, et al.. (2020). Gastrodin protects H9c2 cardiomyocytes against oxidative injury by ameliorating imbalanced mitochondrial dynamics and mitochondrial dysfunction. Acta Pharmacologica Sinica. 41(10). 1314–1327. 41 indexed citations
15.
Sun, Shibo, Chen Chen, Zhiying Weng, et al.. (2019). Isoforskolin and forskolin attenuate lipopolysaccharide‐induced inflammation through TLR4/MyD88/NF‐κB cascades in human mononuclear leukocytes. Phytotherapy Research. 33(3). 602–609. 25 indexed citations
16.
Weng, Zhiying, Guowei Xu, Dingyuan Chen, et al.. (2019). Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 30(2). 126823–126823. 4 indexed citations
17.
Li, Lin, Lu Li, Chen Chen, et al.. (2015). Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-Iα. PLoS ONE. 10(10). e0139570–e0139570. 16 indexed citations
18.
Yang, Weimin, et al.. (2014). Study on General Pharmacology of Forskolin and Isoforskolin. 35(7). 37–40. 1 indexed citations
19.
Li, Lin, et al.. (2014). GW25-e0617 Scutellarin Attenuates Myocardial Ischemia Reperfusion Injury by Inhibiting JAK2/STAT3 Pathway. Journal of the American College of Cardiology. 64(16). C28–C29. 1 indexed citations
20.
Shi, Zhi, Weimin Yang, Dong‐Hua Yang, et al.. (2012). Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Research and Treatment. 135(3). 737–747. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Huang Breakdown of academic impact, for papers by Haibo Cheng Breakdown of academic impact, for papers by Xinhua Xia Breakdown of academic impact, for papers by Ziming Zhao Breakdown of academic impact, for papers by Huishu Guo Breakdown of academic impact, for papers by Sijin Yang Breakdown of academic impact, for papers by Geng Zhang Breakdown of academic impact, for papers by Marialuisa Piccolo Breakdown of academic impact, for papers by Fereshteh Asgharzadeh
Rankless by CCL
2026